No case of overdoses registered.
Grippol® Quadrivalent vaccine against influenza quadrivalent inactivated subunit adjuvant may be administered
concomitantly with inactivated and live vaccines according to National Immunization Schedule (excluding BCG and
BCG-M) and inactivated vaccines from Immunization Schedule by epidemic indications (excluding antirabic vaccines).
However contraindications to each of the used vaccine should be taken into account; the medicinal products should be
administered in different parts of the body using different syringes.
The vaccine should be administered on basis therapy, available in vaccinated disease. The immunization of patients,
receiving immunosuppressive therapy (glucocorticosteroids, cytostatic preparations, radiotherapy) may be less
On day of vaccination the individuals being vaccinated should be examined by a physician (physician assistant) with
compulsory thermometry. The vaccination is not performed at temperature over 37.0 °C
The medicinal product in syringes with disturbed integrity and labeling, with changed physical properties (color,
clarity), with expired date, impaired requirements for storage is not suitable for use.
The incompliance of technique of collection of doses out of multidose vial may reflect in properties of the
medicinal product. Therefore the manufacture is responsible for its quality for 24 hours after the first procedure
of collection only at storage condition in fridge in accordance with manufacturer's guidelines.
Multidose vials Grippol® Quadrivalent contain small quantity of thiomersal as a preservative, which may be a reason
of allergic reaction.
Effect on ability to drive and use machines
Grippol® Quadrivalent vaccine against influenza quadrivalent inactivated subunit adjuvant causes no effect of
ability to drive and use machines.
Solution for intramuscular and subcutaneous injection.
0.5 ml (1 dose) in disposable glass syringes.
5.0 ml (10 doses) with preservative in glass vials, hermetically sealed with rubber stoppers and crimped with
1, 5 or 10 syringes in a blister pack made of polyvinyl chloride film, coated with polymer-coated aluminum foil.
Per 1 (containing 1 or 5 syringes or 10 syringes) or 2 (containing 5 syringes) blister packs in a cardboard box
together with package leaflet.
1 vial in a cardboard pack together with the package leaflet.
20 or 50 vials per cardboard pack with cardboard insert, together with the package leaflet.